Is CBUS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CBUS. It does not provide personalized investment advice.

CBUS (Cibus, Inc. Class A Common Stock) Stock Analysis - Financials

Cibus, Inc. Class A Common Stock (CBUS) is a publicly traded Healthcare sector company. As of September 20, 2026, CBUS trades at $1.61 with a market cap of $123.05M and a P/E ratio of -0.15. CBUS moved -0.61% today. Year to date, CBUS is -7.47%; over the trailing twelve months it is +19.26%. Its 52-week range spans $1.09 to $4.19. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces CBUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CBUS's key financials?

CBUS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CBUS recently traded at $1.61. Market cap is $123.05M. P/E ratio is -0.15. Revenue is $4.26M.

CBUS Key Metrics

Key financial metrics for CBUS
Metric	Value
Price	$1.61
Market Cap	$123.05M
P/E Ratio	-0.15
EPS	$-10.83
Dividend Yield	0.00%
52-Week High	$4.19
52-Week Low	$1.09
Volume	73.00K
Avg Volume	0
Revenue (TTM)	$4.26M
Net Income	$-282.71M
Gross Margin	0.00%

CBUS Analyst Consensus

1 analysts cover CBUS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.

Common questions about CBUS

What are CBUS's key financials?: CBUS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CBUS recently traded at $1.61. Market cap is $123.05M. P/E ratio is -0.15. Revenue is $4.26M.
Is CBUS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CBUS. It does not provide personalized investment advice.